Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original PMA or panel track supplement and may not represent the most recent labeling.
 
DeviceEMIT 2000 CYCLOSPORINE SPECIFIC ASSAY
Generic NameCYCLOSPORINE
Regulation Number862.1235
ApplicantDADE BEHRING, INC.
PO BOX 6101
NEWARK, DE 19714-6101
PMA NumberP920031
Date Received06/29/1992
Decision Date10/02/1996
Reclassified Date 10/16/2002
Product Code MKW 
Docket Number 97M-0082
Notice Date 03/21/1997
Advisory Committee Toxicology
Expedited Review Granted? No
Combination ProductNo
Approval Order Statement  
APPROVAL FOR THE EMIT(R) 2000 CYCLOSPORINE SPECIFIC ASSAY. THE DEVICE IS INDICATED FOR IN VITRO DIAGNOSTIC USE ON THE ROCHE DIAGNOSTICS SYSTEMS COBAS MIRA, COBAS MIRA S, AND COBAS MIRA PLUS CHEMISTRY SYSTEMS FOR THE QUANTITATIVE ANALYSIS OF CYCLOSPORINE (CSA) IN HUMAN WHOLE BLOOD AS AN AID IN THE MANAGEMENT OF CYCLOSPORINE THERAPY IN KIDNEY, HEART, AND LIVER TRANSPLANT PATIENTS.
Supplements:  S001 S002 S003 
-
-